A

Amerisourcebergen Corp
LSE:0HF3

Watchlist Manager
Amerisourcebergen Corp
LSE:0HF3
Watchlist
Price: 305.622 USD -2.12% Market Closed
Market Cap: $63.3B

P/FCFE

19.8
Current
13%
More Expensive
vs 3-y average of 17.6

Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.

P/FCFE
19.8
=
Market Cap
$70.9B
/
Free Cash Flow to Equity
$3B

Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.

P/FCFE
19.8
=
Market Cap
$70.9B
/
Free Cash Flow to Equity
$3B

Valuation Scenarios

Amerisourcebergen Corp is trading above its 3-year average

If P/FCFE returns to its 3-Year Average (17.6), the stock would be worth $271.19 (11% downside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-30%
Maximum Upside
+10%
Average Downside
5%
Scenario P/FCFE Value Implied Price Upside/Downside
Current Multiple 19.8 $305.62
0%
3-Year Average 17.6 $271.19
-11%
5-Year Average 13.9 $214.35
-30%
Industry Average 21.8 $336.87
+10%
Country Average 21.9 $337.65
+10%

Forward P/FCFE
Today’s price vs future free cash flow to equity

Not enough data available to calculate forward P/FCFE

Peer Comparison

All Multiples
P/FCFE
P/E
All Countries
Close

Market Distribution

In line with most companies in the United States of America
Percentile
45th
Based on 7 576 companies
45th percentile
19.8
Low
0 — 13.1
Typical Range
13.1 — 36.5
High
36.5 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 13.1
Median 21.9
70th Percentile 36.5
Max 3 188 432.5

Amerisourcebergen Corp
Glance View

AmerisourceBergen Corp., a titan in the realm of pharmaceutical services, orchestrates the flow of medications across a vast and intricate network. Rooted in Chesterbrook, Pennsylvania, the company has cemented its place as a critical link in the healthcare supply chain. Serving as a bridge between pharmaceutical manufacturers and a wide array of healthcare providers like hospitals, clinics, and pharmacies, AmerisourceBergen leverages its expansive distribution infrastructure to ensure that medications and health products reach their destinations efficiently and reliably. The company's operations are bolstered by its strategic partnerships and collaboration with a plethora of healthcare entities, enabling it to integrate seamlessly into the delivery systems that support patient care. At its core, AmerisourceBergen turns the complexity of healthcare logistics into a streamlined process, generating revenue primarily through the distribution of pharmaceuticals. It purchases medications from manufacturers, sells them at a markup to healthcare providers, and in doing so, balances a robust supply chain fueled by efficiency and scale. But the story doesn't end at distribution; the company has expanded its reach through value-added services such as consulting, data analytics, and patient support services that further solidify its role in the healthcare ecosystem. Whether navigating regulatory environments or advising on patient care strategies, AmerisourceBergen positions itself as not just a distributor, but a partner in health. Through this dual approach of distribution and strategic services, the company ensures it remains vital to both manufacturers and healthcare providers, creating a sustainable business model that capitalizes on both volume and innovation.

0HF3 Intrinsic Value
502.141 USD
Undervaluation 39%
Intrinsic Value
Price $305.622
A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett